Celularity CELU
NASDAQ CELU
$0.80 -0.02 (-2.01%)
As of: Aug 21, 2026 · 3:59 PM EDT

Celularity (CELU) Change in Account Payables (2020 - 2025)

Celularity (CELU) posted quarterly Change in Account Payables of $1.8 million for Q4 2025, down 76.85% year-over-year from $7.9 million in Q4 2024, and up 881.28% quarter-over-quarter from $187000.0 in Q3 2025.

Celularity (CELU) Change in Account Payables (2020 - 2025) Analysis & Trends

Celularity (CELU) has reported Change in Account Payables for 6 consecutive years, with $1.8 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Change in Account Payables fell 76.85% year-over-year to $1.8 million; the TTM figure through Dec 2025 stood at $3.1 million (down 66.17% YoY), while the FY2025 annual figure was $3.1 million, down 66.17% from the prior year.
  • Change in Account Payables rose to $1.8 million in Q4 2025 per CELU's latest filing, from $187000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $7.9 million in Q4 2024 and bottomed at -$3.2 million in Q4 2022.
  • Historically, Change in Account Payables has averaged $1.0 million across 5 years, with a median of $931000.0 in 2024.
  • Annual changes were most pronounced in 2021 — Change in Account Payables jumped 2033.77% — and 2022, when it tumbled 297.5%.
  • Celularity's Change in Account Payables stood at $1.6 million in 2021, then sank by 297.5% to -$3.2 million in 2022, then surged by 153.71% to $1.7 million in 2023, then surged by 354.79% to $7.9 million in 2024, then tumbled by 76.85% to $1.8 million in 2025.
  • Business Quant data shows CELU's Change in Account Payables at $1.8 million in Q4 2025, $187000.0 in Q3 2025, and $1.1 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -8.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 37.53 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Celularity 20.99 Mn 14.82 Mn -3.27 Mn 1.84 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.84 Mn
Dec 31, 2025 1.84 Mn
Sep 30, 2025 187,000.00
Sep 30, 2025 187,000.00
Jun 30, 2025 1.09 Mn
Jun 30, 2025 1.09 Mn
Mar 31, 2025 17,000.00
Mar 31, 2025 17,000.00
Dec 31, 2024 7.93 Mn
Dec 31, 2024 7.93 Mn
Sep 30, 2024 1.71 Mn
Sep 30, 2024 1.71 Mn
Jun 30, 2024 775,000.00
Jun 30, 2024 775,000.00
Mar 31, 2024 -1.17 Mn
Mar 31, 2024 -1.17 Mn
Dec 31, 2023 1.74 Mn
Dec 31, 2023 1.74 Mn
Sep 30, 2023 711,000.00
Sep 30, 2023 711,000.00